{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/schedule-5/paragraph-32",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020/schedule-5/paragraph-32.json",
  "legislation": "wsi/2020/1073",
  "legislation_title": "The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-wales-regulations-2020",
  "path": "schedule/5/paragraph/32",
  "kind": "paragraph",
  "number": "32",
  "heading": "Home Local Health Board of bodies corporate",
  "text": "Where an NHS pharmacist is a body corporate with a registered office in England and Wales, the information to be provided under paragraphs 31 and 35(3) to (6) may be provided instead to a home Local Health Board (as defined in regulation 60). When the NHS pharmacist provides the information to its home Local Health Board, it must also provide the home Local Health Board with details of all the other Local Health Boards in whose pharmaceutical lists the NHS pharmacist is included.",
  "extent": "E+W",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 5 para. 32 in force at 1.10.2020, see reg. 1(2)(b)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/wsi/2020/1073/schedule/5/paragraph/32",
    "retrieved_at": "2026-10-31T10:31:49.207634+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}